Helen Pfister is a Partner in the healthcare practice group of Manatt, Phelps & Phillips, LLP. Ms. Pfister's practice focuses on advising healthcare providers and nonprofit organizations on legislative, regulatory and transactional matters. Her clients include hospitals, community health centers, mental health facilities, substance abuse providers, nursing homes, home care agencies, health information exchange organizations and social service agencies. She has particular expertise representing federally qualified health centers and other organizations that serve medically underserved communities.
Ms. Pfister has extensive experience representing clients before state and federal regulatory agencies, including the New York State Department of Health and the Centers for Medicare and Medicaid Services, and in helping clients navigate the legal and political challenges of Medicare, Medicaid and other public health insurance programs. Her areas of expertise include licensure, reimbursement, fraud and abuse, and other regulatory issues. She also has a strong transactional background, and frequently advises clients on acquisitions, joint ventures, corporate governance, corporate finance and related matters. Ms. Pfister has been heavily involved in advising clients on the federal 340B prescription drug discount program.
Ms. Pfister is also involved in a range of projects involving the use of health information technology to facilitate the secure and timely exchange of health information to improve the quality and efficiency of healthcare delivery. She represents several of New York’s regional health information organizations (RHIOs), and is working on several projects to increase the participation of community health centers and other safety net providers in health information technology initiatives.
Prior to joining Manatt, Ms. Pfister was an attorney in the mergers and acquisitions practice of the law firm of Skadden, Arps, Slate, Meagher & Flom LLP.
Ms. Pfister received her B.A. from Cornell University and her J.D. from Boston University.
She is a co-author of the Bloomberg BNA Health Law & Business Portfolio Series No. 1150, Health Information Technology: Emerging Landscape, Legal Issues and Opportunities.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)